Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06264843 · ClinicalTrials.gov registry record
Peripheral Bypass Trial for Completion Control
A clinical trial of Chronic Limb-Threatening Ischemia, sponsored by Medistim A.
- Recruiting
- Registry status
- 450
- Enrollment target
- 1
- Study location
NCT06264843: Recruiting study of Chronic Limb-Threatening Ischemia, sponsored by Medistim A.
NCT06264843 is a study of Chronic Limb-Threatening Ischemia that is actively recruiting participants, run by Medistim A. The registered enrollment target is 450 participants, above the 135-participant average among 9 other Chronic Limb-Threatening Ischemia trials with a reported enrollment target (233% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06264843, a study of Chronic Limb-Threatening Ischemia, is actively recruiting participants, sponsored by Medistim A.
- RECRUITING
- Registry status
- 450 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the study is to identify and validate flow measurement and ultrasound images in patients undergoing vein bypass surgery below-knee and above ankle
Primary Outcome
Freedom from any repeat graft intervention, graft thrombosis, or clinically significant stenosis (\>70% by either Duplex criteria or angiographic imaging) in the bypass
Conditions Studied
Interventions
- DEVICE MiraQ with Transit-Time Flow Measurement (TTFM) and L15 High Frequency Ultrasound (HFUS) probes
Study Locations (1)
California
- University of California - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2024-11-14 |
| Est. Completion | 2027-12 |
What NCT06264843 shows while recruiting
NCT06264843 is an observational study that tracks outcomes without assigning an intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap, above the 135-participant average among 9 other Chronic Limb-Threatening Ischemia trials with a reported enrollment target (233% higher).
The record links to 1 condition, with Chronic Limb-Threatening Ischemia appearing as the primary indexed condition, and to 1 intervention - of which MiraQ with Transit-Time Flow Measurement (TTFM) and L15 High Frequency Ultrasound (HFUS) probes is the first listed.
NCT06264843 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06264843 about?
NCT06264843 is a clinical study titled "Peripheral Bypass Trial for Completion Control". The goal of the study is to identify and validate flow measurement and ultrasound images in patients undergoing vein bypass surgery below-knee and above ankle
What is the current status of trial NCT06264843?
This trial is currently recruiting. The enrollment target is 450 participants. The study started on 2024-11-14. Estimated completion is 2027-12.
What conditions does trial NCT06264843 study?
This clinical trial studies the following conditions: Chronic Limb-Threatening Ischemia.
What interventions are being tested in trial NCT06264843?
The interventions under investigation include: MiraQ with Transit-Time Flow Measurement (TTFM) and L15 High Frequency Ultrasound (HFUS) probes (DEVICE).
Who is sponsoring clinical trial NCT06264843?
This trial is sponsored by Medistim A, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06264843 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Limb-Threatening Ischemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06264843's enrollment target sits among peer trials
450 1st of 9 higher than 9 of 9 other Chronic Limb-Threatening Ischemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Limb-Threatening Ischemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease
RECRUITING · NA
-
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
RECRUITING · NA
-
AcoArt Litos PCB Below-the-knee Global Trial
RECRUITING · NA
-
Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease
RECRUITING · NA
-
Esprit BTK Post-Approval Study
RECRUITING · NA
-
The ROAMM-EHR Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03047161 · 450 participants
Electrophysiology of Fetal Arrhythmia
- NCT03269630 · 450 participants
New Orleans Pulmonary Hypertension Biobank
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI